CYP2C19 is a drug-metabolizing enzyme, not a direct 'fatigue gene'. Variants (e.g., *2, *3, *17) affect how quickly you break down certain medications – including clopidogrel, proton pump inhibitors (omeprazole), antidepressants (citalopram, sertraline), and benzodiazepines (diazepam). In 'poor metabolizers', higher drug levels can occur, potentially causing fatigue as a side effect. In 'ultrarapid metabolizers', some drugs may be less effective. There is no strong scientific evidence linking CYP2C19 genotype to fatigue in the absence of medication. Fatigue is multifactorial: sleep, stress, diet, iron deficiency, thyroid issues, infections. A DNA test cannot replace medical evaluation. If you take medications, discuss your genotype with your doctor – dose adjustment may be warranted. Evidence: moderate for drug metabolism, unclear for fatigue as a standalone symptom.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-39de574fc3059e76710671ec